UTI - Urinary Tract InfectionCOLLECT-UTINCT07766278
Urine Collection and Novel UTI Biomarkers in Children and Older Adults
An observational study of UTI - Urinary Tract Infection, run by Queen's University, Belfast at 1 site in United Kingdom.
Trial summary
Suspected urinary tract infection (UTI) is a common driver of antibiotic prescribing and hospital admission, yet accurate diagnosis remains challenging. Young children and older adults often present without localising urinary symptoms, and current urine tests perform poorly in these groups. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- UTI - Urinary Tract Infection
- How many people
- 230 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 27 Aug 2026to 17 Aug 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Children under 5 years olds and older adults aged 65 years and over, attending the Royal Victoria Hospital Emergency Departments who are undergoing routine clinical investigation for suspected urinary tract infection.
Who may be able to join
- Children:
- Children under 5 years of age who are not toilet trained.
- Urine dipstick positive for nitrates or leukocytes (including trace).
- Residual urine sample remaining following completion of all routine clinical urine testing.
- Older Adults:
- Adults aged 65 years and over.
- Urine dipstick positive for nitrates or leukocytes (including trace).
- Residual urine sample remaining following completion of all routine clinical urine testing.
Who cannot join
- Consent declined.
- Inability to obtain informed consent.
- Antibiotic treatment within the previous 48 hours for acute infection.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site, 1 recruiting
- Recruiting
Queen's University Belfast
Belfast, Northern Ireland, BT9 7BL
Clare Mills, PhD, 028 9097 6466, clare.mills@qub.ac.uk
About this study
Official title: Urine COLLECTion and Novel UTI Biomarkers in Children and Older Adults (COLLECT - UTI)
Suspected urinary tract infection (UTI) is a common driver of antibiotic prescribing and hospital admission, yet accurate diagnosis remains challenging. Young children and older adults often present without localising urinary symptoms, and current urine tests perform poorly in these groups. In non-toilet-trained children, non-invasive urine collection methods are associated with high contamination rates. In older adults, asymptomatic bacteriuria (ASB) is common and complicates interpretation of urine culture results. As UTIs are a leading cause of sepsis in both groups, this diagnostic uncertainty contributes to overdiagnosis and overtreatment. COLLECT-UTI aims to improve UTI diagnostics by evaluating novel urinary host and bacterial markers to distinguish true UTI from contaminated samples in children and from ASB in older adults.
The COLLECT-UTI study is a prospective observational study of children under 5 years of age and adults aged 65 years and over undergoing testing for suspected urinary tract infection (UTI). The study will recruit approximately 230 participants in total. Clinical features, laboratory results and 14-day outcomes will be recorded on an electronic case report form (CRF) and REDCap database. Residual urine samples collected during routine clinical care will be used to investigate novel urinary host biomarkers and bacterial markers to improve the diagnosis of UTI.
Read the detailed description
Background:
Urinary tract infection (UTI) is one of the most common bacterial infections requiring medical assessment in young children and older adults. Accurate diagnosis is particularly challenging at the extremes of age, where patients frequently present with non-specific symptoms and current urine diagnostic tests perform poorly. In young children, contamination of urine samples collected using non-invasive methods often results in false-positive urine cultures, while in older adults the high prevalence of asymptomatic bacteriuria (ASB) makes it difficult to distinguish bacterial colonisation from true infection. These diagnostic limitations contribute to unnecessary antibiotic prescribing, avoidable hospital admissions and increased antimicrobial resistance. This study aims to evaluate novel urinary host and bacterial biomarkers to improve the diagnosis of UTI by distinguishing true infection from contamination in children and from ASB in older adults.
Objectives:
Primary Objectives:
- Determine the diagnostic accuracy (sensitivity, specificity and AUC) of urinary host biomarkers for diagnosing paediatric UTI across different urine collection methods.
- To characterise the molecular features of urine samples from children with different microbiological classifications of urinary tract infection.
- To characterise the molecular features of urine samples from older adults with symptomatic urinary tract infection and asymptomatic bacteriuria.
Study Design:
A prospective observational study conducted in the Emergency Departments of the Royal Belfast Hospital for Sick Children and the Royal Victoria Hospital. The paediatric component comprises a diagnostic accuracy cohort study with a nested case-control transcriptomic study, while the adult component is a case-control study comparing symptomatic UTI with asymptomatic bacteriuria.
Study Population:
Children under 5 years of age who are not toilet trained and have urine sent for culture for suspected UTI, and adults aged 65 years and over undergoing urine culture for suspected UTI in the Emergency Department. Participants must have sufficient residual urine remaining following routine clinical testing. Exclusion criteria include inability to obtain consent and antibiotic treatment within the preceding 48 hours.
Setting:
Royal Belfast Hospital for Sick Children Emergency Department and Royal Victoria Hospital Emergency Department, Belfast.
Screening:
Potential participants will be identified by the clinical care team. Following informed consent, clinical information and laboratory results will be recorded on a case report form (CRF), with clinical outcomes reviewed 14 days after presentation.
Procedures:
Residual urine samples collected during routine clinical care will be retained following consent. Where available, residual plasma from routine blood sampling may also be stored. No additional urine collection or phlebotomy will be performed for research purposes. Samples will be pseudonymised, transported to Queen's University Belfast for storage and analysis, and used for urinary biomarker measurement, bacterial RNA sequencing and bacterial isolate banking.
Reference Standards:
In children, UTI will be defined using predefined urine culture thresholds according to urine collection method. Samples selected for bacterial RNA sequencing may include urine from children with confirmed UTI, contaminated urine samples and, where available, healthy control samples. In older adults, symptomatic UTI and asymptomatic bacteriuria will be classified using documented urinary symptoms together with urine culture results according to established guideline criteria.
- Conditions
- UTI - Urinary Tract Infection
- Keywords
- Urinary Tract Infection, Paediatrics, Older Adults, Biomarkers, Urine
- Medical subject headings
- Urinary Tract Infections
What is being measured
The primary outcome is the main question the study is designed to answer.
Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) of urinary host biomarkers for paediatric UTI
The diagnostic performance of urinary host biomarkers for paediatric UTI will be evaluated against the reference standard urine culture. Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) will be calculated, with diagnostic performance also compared across urine collection methods.
Measured: 14 days from attendance
Molecular characterisation of paediatric urine samples
Molecular analyses will be performed to identify biological signatures associated with different urine sample classifications, including confirmed UTI, contaminated samples and, where available, healthy controls.
Measured: 14 days from attendance
Molecular characterisation of urine samples from older adults
Molecular analyses will be performed to identify biological signatures associated with symptomatic UTI and asymptomatic bacteriuria.
Measured: 14 days from attendance
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2026
- Study start27 Aug 2026
- Primary completion17 Aug 2028 (estimated)
- Study completion17 Aug 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for UTI - Urinary Tract InfectionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 230 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Queen's University, Belfast
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Thomas Waterfield, Queen's University, Belfast
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07766278
- Sponsor's protocol ID
- NIB26-0004
- Acronym
- COLLECT-UTI
- Status last verified
- Oct 2026
- First submitted
- 7 Aug 2026
- Last updated
- 15 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Urine COLLECTion and Novel UTI Biomarkers in Children and Older Adults (COLLECT - UTI)
- ClinicalTrials.gov ID
- NCT07766278
- Acronym / sponsor ID
- COLLECT-UTI / NIB26-0004
- Conditions
- UTI - Urinary Tract Infection
- Keywords
- Urinary Tract Infection, Paediatrics, Older Adults, Biomarkers, Urine
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 230 participants (estimated)
- Lead sponsor
- Queen's University, BelfastUniversity, hospital or other
- Study start
- 27 Aug 2026 (actual)
- Primary completion
- 17 Aug 2028 (estimated)
- Study completion
- 17 Aug 2029 (estimated)
- First posted
- 14 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Suspected urinary tract infection (UTI) is a common driver of antibiotic prescribing and hospital admission, yet accurate diagnosis remains challenging. Young children and older adults often present without localising urinary symptoms, and current urine tests perform poorly in these groups. In non-toilet-trained children, non-invasive urine collection methods are associated with high contamination rates. In older adults, asymptomatic bacteriuria (ASB) is common and complicates interpretation of urine culture results. As UTIs are a leading cause of sepsis in both groups, this diagnostic uncertainty contributes to overdiagnosis and overtreatment. COLLECT-UTI aims to improve UTI diagnostics by evaluating novel urinary host and bacterial markers to distinguish true UTI from contaminated samples in children and from ASB in older adults.
The COLLECT-UTI study is a prospective observational study of children under 5 years of age and adults aged 65 years and over undergoing testing for suspected urinary tract infection (UTI). The study will recruit approximately 230 participants in total. Clinical features, laboratory results and 14-day outcomes will be recorded on an electronic case report form (CRF) and REDCap database. Residual urine samples collected during routine clinical care will be used to investigate novel urinary host biomarkers and bacterial markers to improve the diagnosis of UTI.
Detailed description
Background:
Urinary tract infection (UTI) is one of the most common bacterial infections requiring medical assessment in young children and older adults. Accurate diagnosis is particularly challenging at the extremes of age, where patients frequently present with non-specific symptoms and current urine diagnostic tests perform poorly. In young children, contamination of urine samples collected using non-invasive methods often results in false-positive urine cultures, while in older adults the high prevalence of asymptomatic bacteriuria (ASB) makes it difficult to distinguish bacterial colonisation from true infection. These diagnostic limitations contribute to unnecessary antibiotic prescribing, avoidable hospital admissions and increased antimicrobial resistance. This study aims to evaluate novel urinary host and bacterial biomarkers to improve the diagnosis of UTI by distinguishing true infection from contamination in children and from ASB in older adults.
Objectives:
Primary Objectives:
- Determine the diagnostic accuracy (sensitivity, specificity and AUC) of urinary host biomarkers for diagnosing paediatric UTI across different urine collection methods.
- To characterise the molecular features of urine samples from children with different microbiological classifications of urinary tract infection.
- To characterise the molecular features of urine samples from older adults with symptomatic urinary tract infection and asymptomatic bacteriuria.
Study Design:
A prospective observational study conducted in the Emergency Departments of the Royal Belfast Hospital for Sick Children and the Royal Victoria Hospital. The paediatric component comprises a diagnostic accuracy cohort study with a nested case-control transcriptomic study, while the adult component is a case-control study comparing symptomatic UTI with asymptomatic bacteriuria.
Study Population:
Children under 5 years of age who are not toilet trained and have urine sent for culture for suspected UTI, and adults aged 65 years and over undergoing urine culture for suspected UTI in the Emergency Department. Participants must have sufficient residual urine remaining following routine clinical testing. Exclusion criteria include inability to obtain consent and antibiotic treatment within the preceding 48 hours.
Setting:
Royal Belfast Hospital for Sick Children Emergency Department and Royal Victoria Hospital Emergency Department, Belfast.
Screening:
Potential participants will be identified by the clinical care team. Following informed consent, clinical information and laboratory results will be recorded on a case report form (CRF), with clinical outcomes reviewed 14 days after presentation.
Procedures:
Residual urine samples collected during routine clinical care will be retained following consent. Where available, residual plasma from routine blood sampling may also be stored. No additional urine collection or phlebotomy will be performed for research purposes. Samples will be pseudonymised, transported to Queen's University Belfast for storage and analysis, and used for urinary biomarker measurement, bacterial RNA sequencing and bacterial isolate banking.
Reference Standards:
In children, UTI will be defined using predefined urine culture thresholds according to urine collection method. Samples selected for bacterial RNA sequencing may include urine from children with confirmed UTI, contaminated urine samples and, where available, healthy control samples. In older adults, symptomatic UTI and asymptomatic bacteriuria will be classified using documented urinary symptoms together with urine culture results according to established guideline criteria.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Children under 5 years olds and older adults aged 65 years and over, attending the Royal Victoria Hospital Emergency Departments who are undergoing routine clinical investigation for suspected urinary tract infection.
Key inclusion criteria (8 listed)
- Children under 5 years of age who are not toilet trained.
- Urine dipstick positive for nitrates or leukocytes (including trace).
- Residual urine sample remaining following completion of all routine clinical urine testing.
- Adults aged 65 years and over.
- Urine dipstick positive for nitrates or leukocytes (including trace).
Key exclusion criteria (3 listed)
- Consent declined.
- Inability to obtain informed consent.
- Antibiotic treatment within the previous 48 hours for acute infection.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) of urinary host biomarkers for paediatric UTI
Time frame: 14 days from attendance
The diagnostic performance of urinary host biomarkers for paediatric UTI will be evaluated against the reference standard urine culture. Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) will be calculated, with diagnostic performance also compared across urine collection methods.
Molecular characterisation of paediatric urine samples
Time frame: 14 days from attendance
Molecular analyses will be performed to identify biological signatures associated with different urine sample classifications, including confirmed UTI, contaminated samples and, where available, healthy controls.
Molecular characterisation of urine samples from older adults
Time frame: 14 days from attendance
Molecular analyses will be performed to identify biological signatures associated with symptomatic UTI and asymptomatic bacteriuria.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Oct 2026.
Related trials for UTI - Urinary Tract Infection
Recruiting
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
Urinary Tract Infections
Active, not recruitingObservational study
Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR
Complicated Urinary Tract Infection
Recruiting
INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS
Drug Resistance, Microbial, Biomarkers
Not yet recruitingObservational study
Comparative Study of the Genomic Characteristics of Uropathogenic Escherichia Coli According to the Severity of Community-Acquired Urinary Tract Infections in Guadeloupe (COLIGENURI)
Urinary Tract Infections
Active, not recruitingObservational study
Characterization of Vaginal, Urinary and Fecal Microbiomes in Women With Recurrent Urinary Tract Infections
Urinary Tract Infections, Menopause
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of UTI - Urinary Tract Infection, run by Queen's University, Belfast at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sensitivity, specificity and area under the receiver operating characteristic curve (AUC) of urinary host biomarkers for paediatric UTI (time frame: 14 days from attendance). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.